CLINICAL_TRIALS
research
· 2024-11-21
Clinical Trial Update: Clinical Study on the Risk of Left Atrial POP Ablation and Esophageal Injury Under Ultra-High Power and Related Influencing Parameters [NA]
Summary
A clinical trial update describing a planned study to evaluate the risk of left atrial injury, including esophageal injury, during ultra-high power atrial fibri…
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Snippet
Sponsor: The Third People's Hospital of Chengdu | Conditions: Ultra-High Power Ablation,Safety of Atrial Fibrillation Ablation | NA | Status: NOT_YET_RECRUITING